Company Filing History:
Years Active: 2025
Title: Elżbieta Pluta: Innovator in Therapeutic Applications
Introduction
Elżbieta Pluta is a notable inventor based in Dębe Wielkie, Poland. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic applications related to chitinase-like protein YKL-40. His work has implications for various medical treatments and diagnostic tools.
Latest Patents
Elżbieta Pluta holds a patent for YKL-40 inhibitors and their therapeutic applications. The patent discloses assays for screening active compounds that interfere with the interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as with heparan sulfate. Additionally, the patent identifies active compounds as inhibitors of YKL-40, detailing their therapeutic applications and their use in biosensors for measuring YKL-40 levels in biological samples. He has 1 patent to his name.
Career Highlights
Elżbieta Pluta is associated with Molecure S.A., where he continues to advance research in therapeutic innovations. His work is characterized by a commitment to improving health outcomes through scientific discovery.
Collaborations
He has collaborated with notable colleagues, including Łukasz Krzemiński and Wojciech J Czestkowski, contributing to a dynamic research environment that fosters innovation.
Conclusion
Elżbieta Pluta's contributions to the field of biochemistry, particularly through his patent on YKL-40 inhibitors, highlight his role as an innovator in therapeutic applications. His work continues to influence the development of medical treatments and diagnostic tools.